Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 3 , Pages 173-183, September 2007

Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides

  • Noha Nafee, PharmD

      Affiliations

    • Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany
    • Faculty of Pharmacy, Department of Pharmaceutics, University of Alexandria, Alexandria, Egypt
  • ,
  • Sebastian Taetz, PharmD

      Affiliations

    • Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany
  • ,
  • Marc Schneider, PhD

      Affiliations

    • Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany
    • Corresponding Author InformationCorresponding author. Biopharmaceutics and Pharmaceutical Technology, Saarland University, Campus Saarbruücken, Bldg. A41, P.O. Box 151150, 66041 Saarbrücken, Germany
  • ,
  • Ulrich F. Schaefer, PhD

      Affiliations

    • Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany
  • ,
  • Claus-Michael Lehr, PhD

      Affiliations

    • Biopharmaceutics and Pharmaceutical Technology, Saarland University, Saarbrücken, Germany

Received 22 January 2007; accepted 15 March 2007. published online 10 August 2007.

Abstract 

Cationically modified poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles have recently been introduced as novel carriers for DNA/RNA delivery. The colloidal characteristics of the nanoparticles—particle size and surface charge—are considered the most significant determinants in the cellular uptake and trafficking of the nanoparticles. Therefore, our aim was to introduce chitosan-coated PLGA nanoparticles, whose size and charge are tunable to adapt for a specific task. The results showed that biodegradable nanoparticles as small as 130 nm and adjustable surface charge can be tailored controlling the process parameters. As a proof of concept, the overall potential of these particulate carriers to bind the antisense oligonucleotides, 2′-O-methyl-RNA, and improve their cellular uptake was demonstrated. The study proved the efficacy of chitosan-coated PLGA nanoparticles as a flexible and efficient delivery system for antisense oligonucleotides to lung cancer cells.

Key words: PLGA nanoparticles, Chitosan, Gene delivery, Antisense oligonucleotides, Telomerase inhibitors

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 No conflict of interest was reported by the authors of this paper.

PII: S1549-9634(07)00089-5

doi:10.1016/j.nano.2007.03.006

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 3, Issue 3 , Pages 173-183, September 2007